C.R. BARD, INC. (BASD) -3006260740 POWERPORT ISP MRI 6CF INT W SP, ATT, SL; PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR
|
Back to Search Results |
|
Catalog Number 8806060 |
Device Problem
Migration (4003)
|
Patient Problem
Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
|
Event Date 12/30/2022 |
Event Type
Injury
|
Manufacturer Narrative
|
As the lot number for the device was provided, a review of the device history records is currently being performed.The return of the sample is pending.The investigation of the reported event is currently underway.(expiration date: 08/2023).
|
|
Event Description
|
It was reported that approximately five months post port placement, the port allegedly migrated cephalad into the jugular vein.The current status of the patient is unknown.
|
|
Event Description
|
It was reported that approximately five months post port placement, the port allegedly migrated cephalad into the jugular vein.The current status of the patient is unknown.
|
|
Manufacturer Narrative
|
H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: one powerport mri implantable port attached to a catheter was returned for evaluation.Gross visual, microscopic visual and functional evaluations were performed on the returned device.A complete circumferential break was noted on the distal end of the attached catheter and the edges of the complete circumferential break were noted to be uneven.The surface was noted to be granular with residue throughout.The investigation is inconclusive for the reported migration issue as the exact circumstances at the time of the reported event is unknown.The definitive root cause could not be determined based upon available information.Labeling review: a review of product labeling documentation (e.G., procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, nursing guide, and unit label) did not find any product labeling inadequacy.H10: d4 (expiration date: 08/2023).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
|
|
Search Alerts/Recalls
|
|
|